Aims: After oral administration, naproxen generates several side-effects related to stomach malfunction. Undoubtedly, the enteric dosage forms with naproxen can be considered as safer. Moreover, since it has been evidenced that development and growth of colorectal cancer is related to the presence of cyclooxygenase, naproxen is investigated in terms of the tumor prevention. The aim of the present work was to formulate and evaluate the properties of novel naproxenloaded macrobeads, made on the basis of low-acyl gellan gum and its blends with carrageenans, guar gum, cellulose sulfate, and dextran sulfates. Method: Seven formulations were prepared by ionotropic gelation. The morphology of the dried beads was evaluated by scanning electron microscopy. The next step focused on Raman spectroscopy and thermal analysis of naproxen, polymers, and the beads. Next, the swelling behavior was examined in three acceptor fluids at pH ¼ 1.2; 4.5, and 7.4. The beads were evaluated regarding naproxen content and encapsulation efficiency. The last stage of the work concerned the drug release studies. Results: Addition of any other polysaccharide than gellan resulted in flattening of the beads upon drying. Differential scanning calorimetry confirmed the crystalline form of naproxen. Raman spectra showed that no apparent interactions occurred. In the acidic environment, all the beads revealed the tendency to absorb water. The beads swelled to the greatest extent at pH ¼ 4.5. Naproxen was released from the beads at a varied rate. At pH ¼ 7.4, the most prolonged release was observed for the beads containing carrageenans. Conclusions: We have proved that blending of gellan with various polysaccharides can change the pH-dependent properties of the beads loaded with naproxen. We believe that the information enclosed in the paper will be of particular importance regarding the development and characteristics of novel oral dosage forms based on natural polymers.
Introduction
Naproxen (NPX) [(þ)-(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid] is a non-steroidal anti-inflammatory drug (NSAID), with analgesic and antipyretic activity. 1, 2 Its mechanism of action involves inhibition of two cyclooxygenase forms, namely COX-1 (constitutive), which is responsible for the physiological synthesis of prostaglandins and COX-2 (inducible), which occurs only at the inflammation site. 3 Additionally, NPX inhibits blood platelets aggregation, but the effect is weaker and shorter than in the case of acetylsalicylic acid. After an oral administration, NPX is absorbed quickly and its biological availability is close to 95%. The most common indications for NPX use are rheumatoid arthritis, 2,4,5 osteoarthritis, tendinitis, 6 bursitis, 7 and acute attack of gout. 8 It is also often used to relieve the migraine symptoms, 9 menstrual pain 10 or pain related to acute injuries. 11 Unfortunately, after oral administration of NPX many more or less severe side-effects are observed. The most frequent are those related to the gastrointestinal tract (GIT) and include stomach pain, dyspepsia, bleeding, ulceration, and vomiting. 12, 13 Patients subjected to long-term therapies also suffer from liver dysfunction, jaundice, headache, edema or kidney malfunctions. [14] [15] [16] [17] On the other hand, since it has been evidenced that the occurrence and growth of colorectal cancer (CRC) are related to the presence of COX-2, [18] [19] [20] NPX, and other NSAIDs (e.g. meloxicam) started to be considered as potential tumor protectors. [21] [22] [23] [24] The concept of enteric delivery of NPX occurred in the seventies of the past century 15, [25] [26] [27] but the topic still arises a large interest among the researchers. The easiest way to shift the drug release to the small intestine or more distant parts of the GIT (colon) is coating or incorporation into polymeric matrices which are stable in the acidic environment and decompose after pH increase. 28 A common method involves the use of synthetic polymers, i.e. Eudragit V R RS 29, 30 ; however, very good results are also obtained with naturally derived polymers. [31] [32] [33] These include for example pectins, chitosan, 34 amylose, 35 chondroitin sulfate 36 or gellan gum. [37] [38] [39] Very promising results were obtained by encapsulation of NPX into PVA/sodium alginate crosslinked blend beads 28 or incorporation to alginate/chitosan microparticles, 40 chitosan hydrogel loaded with carbon nanotubes, 41 pullulan acetate microspheres, 42 interpenetrating polymer network (IPN) microspheres, 43 polymeric carriers with NPX pendant groups, 44 cellulose acetate phthalate beads 45 or Ca-alginate microparticles, cross-linked by chitosan oligosaccharide. 40 As it was shown in some reports, one of the naturally derived polysaccharides with the potential for pH-dependent drug release is gellan gum. 15, 46, 47 It is a linear, anionic polymer, produced in a fermentation process by the bacteria Sphingomonas elodea. Gellan chain is composed of a repeating tetrasaccharide unit, containing a-L-rhamnose, b-D-glucose and b-D-glucuronate. [48] [49] [50] Two forms of gellan gum are currently in use. The first one is characterized by the presence of acyl substituents and is known as high-acyl (HA) or native gellan. The second is called low-acyl (LA) or deacetylated and is obtained by alkaline hydrolysis of HA gellan. 51 Both forms are readily soluble in hot water (at least 70 C).
During the temperature decrease, the entangled polymeric chains undergo coil-to-helix transition. As a result, HA gellan gives soft and deformable hydrogels, while LA congeals to hard and brittle gels, similar to agar. 52, 53 The gelation process of LA gellan is highly ion-sensitive. Upon the contact with cations, the polymer chains undergo cross-linking which results in the formation of a three-dimensional network. The process is defined as ionotropic gelation and can be applied for encapsulation of drugs, proteins, probiotics etc. [54] [55] [56] To obtain gellan beads loaded with active pharmaceutical ingredient (API), the drug-polymer mixture must be instilled to the solution of cations. In most cases, Ca 2þ or Al 3þ are used. 38, 57, 58 The gelation process is very rapid and the spherical beads are formed with the drug enclosed inside. Usually, the beads are dried and in this form can be stored or applied to the patient. Dry gellan beads are resistant to the acidic environment but at higher pH begin to swell, disintegrate and as a result the drug is released. 47, 59, 60 Taking into account the mentioned gastric side-effects associated with NPX and its possible antitumor activity, it is fully justified to conduct studies and design novel colonic carriers for the drug. As it was shown in our previous studies, the pH-dependent behavior of NPX-loaded gellan beads strictly corresponded to the amount of the polymer and drug used during production. 61 The aim of the present work was to investigate whether the addition of various naturally derived polymers to gellan influence the properties of the beads. For the investigation, we have prepared the beads with gellan blended with six naturally derived polymers. In each formulation the amount of NPX was constant. First, the beads were examined using Raman spectroscopy, differential scanning calorimetry, and electron microscopy. Further, drug encapsulation efficiency, swellability index and in vitro drug release were investigated. The purpose of the performed studies was to broaden the knowledge concerning the drug release from simple and complex matrices containing polymers revealing different properties, also the ability to swell in GIT in the whole pH range. This decision was supported by the results of other studies indicating that gellan gum matrices obtained as a result of ionotropic gelation reveal burst release in slightly alkaline conditions and the sustained release which is necessary to obtain the therapeutic effect in distal parts of GIT is rather poor. 55, 62 Several different criteria were taken into consideration during the selection of additional macromolecular components. First of all, the substances applied in our study can be safely used as excipients in pharmaceutical products. Another important factor was the ability to swell and form hydrophilic matrix potential to release the drug in a prolonged manner.
Carrageenans are naturally occurring sulfated polysaccharides obtained from red seaweed (Rhodophyceae). Their main backbone consists of sulfated galactose and 3,6-anhydrogalactose moieties linked with a-1,3 and b-1,4 bonds. The classification of carrageenans is based on the presence or absence of anhydrogalactose and the location of sulfate groups. ı-Carrageenan contains about 36% of anhydrogalactose and 32% (w/w) ester sulfate which corresponds to two sulfate ester groups per disaccharide unit. 63 It reveals gelling ability and forms shearthinning thixotropic gels with properties dependent on the presence of cations. Its characteristics make it an interesting excipient for prolonged release tablets, pellets, and microcapsules. 63 Guar gum is a polysaccharide obtained from the endosperm of Cyamopsis tetragonolobus. 64 Its main backbone consists of D-mannose moieties connected with b-1,4 bonds. Some of the mannose units are substituted with D-galactose moieties. The polymer reveals the ability to swell both in cold and hot water and forms the dispersions with a wide range of viscosities, from viscous solutions to thick gels. 65 It has been widely used as a food additive. 66 In pharmaceuticals, it can be utilized as a binder and disintegrant in solid dosage forms and thickening or stabilizing agent in liquid formulations. 65 Cellulose sulfate is an anionic polymer obtained by esterification of cellulose. It is known as a noncytotoxic agent revealing some antimicrobial and contraceptive properties. 67 It was also investigated as a preventive agent reducing the risk of human immunodeficiency virus (HIV) infections; however, the phase III clinical trials ended with failure. 68 It is noteworthy that because of the presence of negative charge in the molecule cellulose sulfate can form complexes with cationic polymers, e.g. chitosan. 69 Dextran sulfate is a branched glucan with main backbone consisting of D-glucose units connected by a-1,6 bonds and side chains attached mostly with a-1,6 bonds. 70 Approximately 2.3 sulfate groups per one glucose unit are present in the polymer molecule.
Dextran is most commonly known as a plasma volume expander. 71 However, it has also been investigated for the conjugation with active substances to minimize their side effects. 72 Dextran sulfate is an anionic polymer which can form complexes with cationic macromolecules, like chitosan. 71 Both cellulose and dextran sulfates were selected because of the negative charges present in the molecules and the possibility to interact with ionized carboxyl groups of gellan gum. 
Materials and methods

Materials
Methods
Composition and preparation of NPX-loaded gellan beads. The beads were prepared with of ionotropic gelation. Initially, the polymer, drug, and surfactant mixtures were prepared. The percent amounts of the ingredients in seven mixtures (F1-F7) are presented in Table 1 . First, the polymer was poured on the surface of deionized water (ambient temp.) in an Erlenmeyer flask and left to moisten and swell. The flask was closed with a rubber septum to avoid evaporation of water. After 10 min the temperature increased to 80.0 AE 2.0 C under constant stirring on a RET control-visc magnetic stirrer (IKA, Staufen, Germany). When a clear polymer solution was obtained, the temperature decreased to 70 C and Tween V R 80 was added. After 2 min NPX was carefully poured and the mixing continued until a homogenous suspension was achieved. The suspension was taken out from the flask by a 20 mL syringe. The syringe was placed in an NE-1000 syringe pump (New Era Pump Systems, Inc., USA). The drug-polymer mixture was transferred to the solution of calcium chloride (9.0 Â 10 À2 M) through Var J1 encapsulation unit (NISCO Engineering AG, Zurich, Switzerland).
The air flow through the encapsulator was set at 100 L/h. The medium (60 mL) was constantly mixed in a beaker. The temperature of the medium was ambient. After 15 min (curing time) the beads were collected by decantation, washed threefold with the distilled water, filtered through a sieve and dried at 37 AE 2 C for 24 h in ING 400 heater with the gravitational air circulation (Memmert GmbH, Germany). The dried beads were stored in closed string bags at ambient temperature.
Scanning electron microscopy (SEM) of the beads. NPX and dry beads were fixed to a stand using a double-sided adhesive tape. To obtain the electrical conductivity, the beads were coated with gold under vacuum in Bal-Tec SCD 050 sputter coater (Bal-Tec Balzers, Liechtenstein) for 75 s and at 17 kV. The samples were examined under the magnification of 100Â and 2500Â by a scanning electron microscope Evo V R 40 (Zeiss, Germany).
Raman analysis of NPX, polymers, and the dried beads. The non-polarized Raman spectra were recorded in the backscattering geometry using inVia Renishaw microRaman system (Renishaw, New Mills, UK). The Raman scattering spectra were investigated in the spectral range of 100-3200 cm À1 . Infrared solid-state laser operating at 785 nm was used as a source of exciting light. The laser beam was tightly focused on the surface of the sample through Leica 50Â LWD microscope with long working distance objective (LWD) (Leica, Wetzlar, Germany), with a numerical aperture (NA) equal to 0.5. The laser beam diameter was equal to 2 lm. The air-cooled charge-coupled device (CCD) camera detector (Rencam) and 1800 lines/mm diffraction grating were used. To prevent any damage of the sample an excitation power was fixed at no more than 10 mW. The samples were studied at room temperature (296 K). The Raman scattering spectra for NPX powder, gellan gum, and all dried beads were obtained in the same spectral conditions (temperature, laser power, scattering geometry).
Differential scanning calorimetry (DSC). DSC curves were obtained using a DSC 2920 TA Instrument Inc. (New Castle, DE USA). Samples (2-6 mg) were placed in a standard 40 mL aluminum pan with pierced lids and heated with 10 C min À1 rate from 25 to 170 C under a nitrogen gas flow of 50 mL min
À1
. An empty pan was used as a reference. The equipment was calibrated with indium (m.p. ¼ 156.65
). All values were determined using TA Universal Analysis 2000 V4.5A (New Castle, DE USA). Swellability index. The swelling behavior of the dried beads was studied in three different acceptor fluids assigned as AF1-AF3 (see Table 2 ). Initially, approximately 15.0 mg of the beads were placed in the beakers (25 mL) and immersed in 5 mL of the AF (previously heated to 37.0 AE 0.5 C). Then the beakers were fixed to KS 130 Control orbital shaker (IKA V R , Staufen, Germany), located in BD 30 heater with the gravitational air circulation (Binder, Gleisdorf, Austria) and mixed at 140 r/min. After certain periods of time (1, 2, 4, and 6 h) the beads were removed from the fluid, gently blotted up with the paper towel and weighed. After weighing, the beads were immersed in the fresh portion of the fluid. The swelling index (SI) was calculated using the equation (1) 72
where W1 is the weight of dry beads and W2 is the weight of the swollen beads.
Determination of NPX content and loading efficiency into the beads. The dried beads were weighed in the amounts equal to theoretical 5.0 mg of NPX, poured to glass volumetric flasks and immersed in 25 mL of AF3 (phosphate buffer pH ¼ 7.4) in the closed glass flasks. The flasks were placed on the orbital shaker (KS 130 Control; IKA V R ) in the heater (BD 30, Binder, Gleisdorf, Austria). The temperature was set at 37.0 AE 0.5 C. After 24 h, the resultant dispersions were filtered to the test tubes through 3 h grade fluted paper filters (Spezialpaper FILTRAK GmbH, Niederschlag, Germany). The first 5.0 mL of the filtrate was rejected. The next portion was subjected to the spectrophotometric analysis. The absorption at 331 nm was determined with the use of UV-2401PC spectrophotometer (Shimadzu, Kyoto, Japan). AF3 (Table 2 ) was used as the blank sample. The drug loading and drug encapsulation efficiency were calculated according to Nayak et al. 73 using equations (2) and (3) Drug loading % ð Þ ¼ amount of NPX in the beads mass of the beads Â 100
In vitro drug release studies. The drug release studies were performed on DT 60 USP 1 apparatus-rotating basket (Erweka GmbH, Heusenstamm, Germany). Each vessel of the apparatus was connected to Evolution TM 300 PC spectrophotometer (Thermo Scientific, Madison, USA) by MCP peristaltic pump (Ismatec V R , Wertheim, Germany). The spectrophotometer was equipped with a linear 8-cell changer and a set of quartz flow-through cells, l ¼ 10 mm (Starna Scientific, Hainault, UK). The system was working in the closed-loop mode. The weighed samples of the beads containing $30.0 mg of NPX were placed in the baskets and immersed for 2 h in 500.0 mL HCl/ NaCL solution (AF1) at pH ¼ 1.2. Subsequently, AF1 was replaced with phosphate buffer pH ¼ 7.4 (AF3). Previously the AF was degassed and heated to 37 AE 0.5 C. The total time of the experiment was 12 h. The rotation speed of the baskets was set at 100 r/ min. The absorbance at 381 nm (background) and 331 nm (signal) was measured at every 15 min. The experiment was conducted simultaneously for enteric coated (ethyl acrylate/methacrylic acid co-polymer) tablets Anapran V R EC 250 containing 250.0 mg of NPX.
Statistical analysis
The statistical analyses were performed with Statistica 12 software (StatSoft Inc., Tulsa, OK). 74 The results obtained for the investigated formulations were subjected to one way analysis of variance (ANOVA). For the comparison of the mean values of the analyzed parameters post-hoc Scheffe's test was used. In all performed tests the significance level was set at 5%.
Results and discussion
Morphology of the beads
Many different factors including concentration and type of the polymer, physicochemical properties of the drug or additives, as well as the type of the crosslinking ions, can have an impact of the properties of the beads obtained by ionotropic gelation. 37, 39, 61, 74 Moreover, the parameters of the final product can be affected by the conditions during the production process i.e. temperature of the drug-polymer mixture, instillation flow rate, diameter of the tubes and the needle, height of instillation, mixing speed of the gelling medium or curing time. 61, 75 As can be concluded from the experimental part, the NPX-loaded beads were produced under constant conditions and the main goal was to investigate the influence of the polymer composition on the properties of the beads. During preparation of polymer-drug mixtures, it was necessary to add Tween V R 80 to achieve the homogenous suspension. Without the surfactant, NPX formed agglomerates which resulted in clogging of the encapsulator. Moreover, as we have shown in our previous work, 61 Tween V R 80 can have an influence on the beads formation process and their shape. Based on the visual observations, it was concluded that the shape of the wet beads was similar to spherical or slightly oval ( Figure  1 ). The differences occurred during drying. As can be seen in Figures 2 and 3 , the dehydrated beads prepared from gellan gum alone (F1) were tear-like in shape. Their surface was less irregular than in the other formulations. Moreover, the presence of NPX crystals was not visible. According to the beads containing carrageenans (F2 and F3) it was observed that after gelation their shape was the most similar to spherical, but as the drying proceeded the three-dimensional network collapsed and the matrices took the shape of flattened discs. It could be seen that the surface was wrinkled and NPX crystals were partially attached to the outer layer. Similar effects were confirmed for the rest of the formulations (F4-F7). However, additionally the tendency to aggregation was noticed. In the case of dextran sulphate, 500 kDa (F7) the dried beads had sharp edges and their shape was far away from spherical.
Raman analysis of NPX, gellan and the beads
Raman analysis was carried out for pure polymers (P1-P6), dried beads (F1-F7), and NPX powder in the spectral range of 100-3200 cm À1 (see Figure 4) .
Unfortunately, in the case of dextran sulphate (P7) it was not possible to record the Raman spectrum within the chosen range because of strong Rayleigh light scattering and intense luminescent background. The study performed with altered experimental parameters would give results impossible to compare with the other samples. Therefore, P7 was excluded from Raman analysis. Table 3 presents the bands selected from the spectra with the use of normal mode analysis and types of vibrations assigned to them. In all the examined formulations the observed Raman spectra were similar to the spectrum of pure NPX. There were no changes in both the position of the Raman bands and their intensity ratio. The effect of polymer change on Raman spectra of the dried beads was also not observed. Only in the case of polymer P2 and formulation F2 the increase of the luminescent background in Raman spectra derived from the P2 polymer (ı-carrageenanCargill) was observed.
Differential scanning calorimetry (DSC)
The identification of possible interactions between API and other excipients is extremely important at an early stage of drug development process. Thermal analysis is frequently used to study the drug-drug and drugexcipients compatibility. DSC quickly provides information about possible interactions among the formulation components, according to the appearance, shift or disappearance of phase transition peaks and/or variations in the corresponding enthalpy values calculated for drug-drug/excipient physical mixtures. [76] [77] [78] However, the interpretation of the thermal data is not always trivial and minor changes in the melting endotherm peak of API can occur due to the mixing of the components, which, indeed, lowers the purity of each component in the mixture/formulation. In this case, broadening of the peak and changes in the enthalpy of fusion may not necessarily indicate incompatibility, therefore, the use of complementary analytical techniques, such as Raman spectroscopy, X-ray powder diffraction (XRPD) or Fourier-transform infrared spectroscopy (FTIR) techniques is advisable.
78-82 Figure 5 shows standard DSC plots of crystalline NPX, single polymers (P1-P7) and formulations (F1-F7) recorded with 10 C min
À1
heating rate. The DSC curve of NPX shows one sharp endothermic peak with an onset at 155.7 C and an enthalpy of fusion DH NPX ¼ 138.0 J g À1 due to melting as previously reported by us. 61 The summary of DSC data is shown in Table 4 . The melting peak of NPX in the formulation is clearly observed, confirming its presence in a crystalline form in the beads; however, some dislocations in the melting temperature as well as in the enthalpy of fusion in all the formulations are seen. The temperature decreases as peaks broaden and enthalpy of fusion changes (since there is only around 44% of the drug in the formulation, the expected value of enthalpy in the formulations is about 61 J g
). However, these minor deviations not necessarily indicate incompatibility as confirmed by Raman spectroscopy.
Swellability index
The tendency to absorb water by the beads was investigated in three media (Table 2) at different pH values, corresponding to the conditions present in the GIT after administration of the drug dosage form. The results are presented in Figure 6 as the dependence of the SI (see equation (1)) vs. time. Below are given the ordered sequences according to decreasing SI after 6 h (the SI 6h values are included in the brackets) Figure 5 . DSC curves recorded for pure NPX, pure polymers (P1-P7) and the dried beads (F1-F7). As expected, in AF1 (pH ¼ 1.2) the beads prepared from pure gellan were the most resistant to water uptake (SI 6h $ 110%). On the other hand, it can be observed that blending with ı-carrageenan (Ricovis V R ) resulted in the highest SI 6h value of almost 500%. Taking into consideration the results obtained after 6 h at pH ¼ 1.2, only formulations F4 and F6 revealed no statistically significant differences when compared to F1. Moreover, the statistical analysis revealed significant differences between formulations F2 and F3 containing carrageenan obtained from two different commercial sources, as well as F6 and F7 containing dextran sulfate differing in molecular weight. In all cases, swelling in AF1 was proceeding up to 2 h and after that time reached an equilibrium. It must be considered that even though the beads were dried with the proper care, some traces of water could not be entirely removed from the surface and the furrows. Therefore, in some cases, the obtained results can be slightly inflated. Much more efficient water absorption was observed in the other two fluids. It can be seen that in AF2 (pH ¼ 4.5) all the beads revealed the highest SI 6h values. Moreover, the beads did not lose the shape and their consistency remained elastic. Also no visible discoloration was noticed, which suggested no excessive loss of NPX from the polymer network. Surprisingly, during the first hour of the experiment, swelling in both AF2 and AF3 proceeded in a very similar manner. After that time the beads at lower pH continued swelling with the increasing tendency until the end of the assay, whereas in the alkaline environment the tendency to reach the equilibrium was observed and from the second hour there was no considerable mass increase. In the case of AF2 the most efficient water uptake revealed F1 beads (pure gellan), whereas sample F3 (gellan þ carrageenan ıR) swelled to the lowest degree. The statistical analysis revealed significant differences between F1 and macrobeads modified with other polymers. Again, statistically significant differences were observed for F2 and F3, as well as for F6 and F7. This observation indicates that carrageenan supplied by two manufacturers affected the behavior of gellan gum differently. It was also shown that the molecular weight of the polymer is an important factor affecting the properties of the final product and its performance as a drug delivery system. However, it must also be considered that in physiological conditions, after oral administration the beads will be subjected to pH ¼ 4.5 for a very short time of approximately 15 min. As can be concluded from Figure 7 , after such a short time the mass increase of the beads can be regarded as negligible. In pH ¼ 7.4 (AF3) swelling was less rapid but after the first hour the beads started to soften and at the end of the assay were far from spherical. It also could be observed that a gradual discoloration occurred and at the final stage the beads were fully transparent, which was interpreted as drug release. Moreover, it was observed that the beads were surrounded by a flocky layer, which can be interpreted as the erosion of the polymer matrix. Additionally, it can be concluded that in general the plots obtained from pH 1.2 and 7.4 showed very similar course.
The behavior of all investigated beads in pH ¼ 7.4 indicates that the obtained matrices are more susceptible to swelling in less acidic conditions. This observation is important regarding the prediction of the behavior of the analyzed systems in the GIT. It is important to note that according to the observed pH-dependent effects the obtained polymer-based systems seem to be suitable for shifting the drug release to the distal parts of GI tract. It may be assumed that the weakening of the interactions between the polymer chains and matrix erosion will contribute to more efficient drug dissolution in the intestines. Taking into consideration the statistically significant differences, it may be assumed that F1 containing only gellan gum differed from all other formulations except for F6. Again, statistically significant differences depending on the carrageenan source were observed, as well as the differences related to the molecular weight of dextran sulfate. It was shown that in the case of F2 at pH 4.5, SI was higher than for F3; however, at pH 7.4 formulation F2 swelled less intensively than F3. The observed differences may also relate to the effects Figure 7 . NPX content in the beads and the encapsulation efficiency.
related to the drug release in the GIT. In formulations containing two different dextran sulphate types, swelling behavior was dependent on the molecular weight of the polymer. Formulation F6 containing the polymer of lower molecular weight swelled more intensively which was most probably related to the ability of the complex matrix to absorb water. In the case of high molecular weight polymers, the matrix is thicker and water penetration is therefore hindered.
It is important to notice that for all samples the highest swelling ability was observed at the intermediate pH value, i.e. 4.5. This effect may be related to the composition of AF2 medium which in our study contained acetate buffer. According to Norton and Lacroix, 83 acetate buffer can reveal some chelating properties towards divalent cations which are essential for ionotropic gelation process of gellan. The application of acetate buffer in our study could decrease the amount of calcium ions necessary to form bridges between the polymer chains. This effect may contribute to the decrease of gel strength and more robust swelling process.
Determination of NPX encapsulation efficiency and content in the beads
The quantitative analysis of NPX was performed by means of ultraviolet spectrophotometry. Before the preparation of the calibration curve, the UV spectra (200-400 nm) were plotted separately for water solutions of all polymers and Tween V R 80, to exclude overlapping with NPX spectrum and to confirm that no addition of the absorption at the analytical wavelength (381 nm) occurs (data not shown). The concentrations of all components were at least twice as high as in the experiments. The percent NPX encapsulation efficiency (EE) (black) and drug content (DC) (gray) in the beads are presented in Figure 7 . It can be observed that in the case of pure gellan beads and the blends with carrageenans and cellulose sulfate (F1-F4) both the values were similar and close to 90% (EE) and 40% (DC). Higher values of EE and DC were observed for the formulations containing guar gum and dextran sulfate (F5-F7). The observed differences were statistically significant.
Drug release studies
To simulate the passage through the GIT, the drug release experiments were performed in a two-step procedure. First, the beads were immersed for 2 h in HCl/ NaCl (AF1) at pH ¼ 1.2, to mimic the conditions similar to the stomach. Subsequently, AF1 was replaced with phosphate buffer (AF3, pH ¼ 7.4) and the experiment proceeded for another hour. In physiological conditions, this pH is characteristic to the ileum. The obtained results were compared to NPX release from the commercially available enteric-coated tablets Anapran V R EC 250 mg. The main component of the tablet coating which provides the resistance to the acidic environment is methacrylic acid-ethyl acrylate copolymer (1:1). The results are presented in Figure 8 as the dependency of % NPX release vs. time. As can be seen, all the tested formulations revealed the properties of modified drug release. During the first 2 h (pH ¼ 1.2) the commercial tablets were stable, did not disintegrate and no NPX release was recorded. In the case of the beads, NPX was released to the acidic medium with a variable rate. The release process was most efficient for F4 (GG þ cellulose sulfate) and after 2 h reached almost 20%. The slowest release was observed for the beads prepared from pure gellan (8.4%). The very similar release was observed for the beads containing guar gum (9.3%). The statistical analysis revealed no significant differences between these beads. Therefore, these two formulations can be potentially regarded as enteric because they comply with the European Pharmacopeia requirements, according to which the drug release during 2 h in 0.1 M HCl cannot exceed 10%. 84 The slight release of NPX from the beads is probably related to the fact that the drug is not fully immobilized in the polymer matrix but also attached to the surface. Therefore, the crystals are able to detach from the beads freely and partially dissolve in the medium. During the second step of the experiment (medium change for pH ¼ 7.4) all tested formulations revealed immediate NPX release in short period, up to 1 h. The commercial tablet disintegrated very rapidly and after 15 min 80% of the drug dose was released. Among the beads the amount of NPX released at the same time was in the range from 74% (F6) to 96% (F4) (Figure 8 ). Below are given the ordered sequences according to increasing % release after 15 and 60 min in pH ¼ 7.4 (the values are included in the brackets). However, it must be emphasized that at the final stage of experiment no statistically significant differences were observed between the formulations F1-F7. After 15 min only F4 differed from pure gellan gum. Therefore, it may be assumed that the modifications of gellan matrix with other polymers affected mainly its behavior in acidic conditions. During the first 15 min the beads assigned as F3 (carrageenan ıC), F2 (carrageenan ıR), and F4 (cellulose sulfate) released more than 90% of NPX. The release onset was most delayed from the beads containing dextran sulfate 5 kDa (F6)-73.8%. In this case, at the end of the experiment 94% of the drug was released. In our previous works concerning the NPXloaded beads prepared of different amounts of pure gellan we have reported that the release rate from the beads depended on two processes, i.e. drug diffusion as a result of matrix structure weakening and the drug diffusion from the bead surface to the acceptor medium. The most important factor determining the drug release rate in these systems is polymer chain mobility. Another process that may be involved in the drug release mechanism is polymer matrix erosion. 61 
Conclusions
Since many years the issue of NSAIDs delivery to the colon has gained a large interest. The results presented in this work clearly demonstrate that NPX crystals can be encapsulated into the gellan gum macro beads. The aim of the studies was to investigate the impact of various polymers on the properties of gellan macrobeads obtained under constant conditions. Taking into consideration the morphology of the obtained systems, the most important factor was the composition of the matrix. The partial replacement of gellan gum with other polymers led to less regularly shaped beads with NPX crystals exposed at the surface of the polymer matrix. It is also noteworthy that the formulations containing other polymers revealed tendency to collapse, flatten, and aggregate during drying. The physicochemical analyses comprising Raman spectroscopy and DSC studies revealed no significant symptoms of the possible interactions between NPX and the excipients employed in the formulations. The results of swelling and drug release studies indicate that the obtained systems reveal pH-dependent properties which may be employed for the modification of drug release process in the GIT. The observations of swelling behavior show that the investigated matrices have the tendency to swell and erode at pH ¼ 7.4 which may also contribute to the increased drug release rate. The observations made for the acidic conditions are ambiguous. The beads seem to be resistant to pH ¼ 1.2 but swell significantly at pH ¼ 4.5. Nevertheless, the latter value may be considered as non-significant regarding physiological conditions. The results obtained in drug release experiments confirm the conclusions made based on the previous experiments. The investigated systems released most of the incorporated NPX at pH ¼ 7.4 which indicates the possibility to modify the drug release. In the analyzed formulations the process can be partially shifted to the distal parts of GIT which may be employed in the formulations designed for colon cancer chemoprevention. However, it must be emphasized that NPX employed as a model active ingredient in this study is a weak acid which may also contribute to the better dissolution at slightly alkaline conditions. Therefore, the effects observed in this study should be considered as a superposition of two effects: the pH-dependent behavior of the matrix and the acidic properties of the drug.
